Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Reports of heart valve disease associated with fenfluramine, texfenfluramine, and phentermine raised concerns about drug treatment of obesity since 2000 [10,11]
Who may be a good candidate for retatrutide therapy
Clinical trial data demonstrates that both agents can achieve substantial weight loss, with Retatrutide achieving up to 24% body weight reduction and Mounjaro providing significant weight loss with proven glycaemic benefits
-Cell dedifferentiation in patients with T2D with adequate glucose control and nondiabetic chronic pancreatitis
[4] [5] The three primary subcutaneous injection sites used for comparable licensed therapies (such as semaglutide and tirzepatide, as described in their UK Summary of Product Characteristics) are: Abdomen the area around the stomach, avoiding the area immediately around the navel Front (anterolateral) thigh the outer-front portion of the upper thigh Upper arms the outer area of the upper arm, typically requiring assistance from another person for self-administration The abdomen is generally considered the most accessible and commonly used site, as it offers a relatively large surface area of subcutaneous fat and is straightforward to self-administer
US$ 27.94
US$ 28.94
US$ 20.02
US$ 23.93
US$ 25.25
US$ 28.86
US$ 25.39
US$ 24.62
US$ 28.46
